Us Bancorp \De\ Eagle Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$17.74 - $31.87 $10,821 - $19,440	-610 Reduced 97.6%	15 $0
Q1 2023 May 09, 2023	SELL	$25.06 - $34.09 $4,285 - $5,829	-171 Reduced 21.48%	625 $17,000
Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $6,944 - $11,056	278 Added 53.67%	796 $23,000
Q3 2022 Oct 27, 2022	SELL	$26.42 - $47.12 $9,537 - $17,010	-361 Reduced 41.07%	518 $14,000
Q2 2022 Aug 01, 2022	BUY	$41.26 - $51.35 $12,460 - $15,507	302 Added 52.34%	879 $39,000
Q1 2022 May 11, 2022	SELL	$44.58 - $52.6 $319,192 - $376,616	-7,160 Reduced 92.54%	577 $29,000
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $3,711 - $4,608	-81 Reduced 1.04%	7,737 $394,000
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $21,895 - $27,890	-500 Reduced 6.01%	7,818 $437,000
Q2 2021 Aug 05, 2021	SELL	$36.86 - $44.5 $11,537 - $13,928	-313 Reduced 3.63%	8,318 $356,000
Q1 2021 Apr 28, 2021	BUY	$40.32 - $50.97 $1,774 - $2,242	44 Added 0.51%	8,631 $361,000
Q4 2020 Feb 04, 2021	SELL	$41.72 - $51.34 $6,633 - $8,163	-159 Reduced 1.82%	8,587 $399,000
Q3 2020 Nov 10, 2020	SELL	$37.02 - $51.28 $27,061 - $37,485	-731 Reduced 7.71%	8,746 $371,000
Q2 2020 Aug 07, 2020	SELL	$43.24 - $55.02 $36,408 - $46,326	-842 Reduced 8.16%	9,477 $454,000
Q1 2020 May 13, 2020	BUY	$34.37 - $60.07 $6,495 - $11,353	189 Added 1.87%	10,319 $475,000
Q4 2019 Feb 04, 2020	BUY	$54.32 - $64.31 $54,320 - $64,310	1,000 Added 10.95%	10,130 $608,000
Q3 2019 Nov 08, 2019	BUY	$53.25 - $59.98 $45,848 - $51,642	861 Added 10.41%	9,130 $517,000
Q2 2019 Aug 13, 2019	BUY	$46.61 - $58.45 $19,902 - $24,958	427 Added 5.45%	8,269 $460,000
Q1 2019 May 08, 2019	BUY	$38.66 - $51.82 $20,992 - $28,138	543 Added 7.44%	7,842 $396,000
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $150,074 - $276,812	4,087 Added 127.24%	7,299 $295,000
Q3 2018 Nov 01, 2018	BUY	$66.65 - $83.86 $29,659 - $37,317	445 Added 16.08%	3,212 $223,000
Q2 2018 Aug 08, 2018	BUY	$51.25 - $76.62 $93,223 - $139,371	1,819 Added 191.88%	2,767 $209,000
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $44,195 - $57,221	948	948 $57,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account